Jacob B. Frieberg - 23 Oct 2023 Form 4 Insider Report for VACCINEX, INC. (VCNX)

Role
Director
Signature
/s/ Scott E. Royer, Attorney-in-Fact for Jacob B. Frieberg
Issuer symbol
VCNX
Transactions as of
23 Oct 2023
Net transactions value
-$8,694
Form type
4
Filing time
25 Oct 2023, 16:30:44 UTC
Previous filing
05 Oct 2023
Next filing
14 May 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding VCNX Common Stock 4,235 23 Oct 2023 Direct
holding VCNX Common Stock 6,301 23 Oct 2023 By Benbow Estates, Ltd. F1
holding VCNX Common Stock 12,870 23 Oct 2023 By Gee Eff Services Limited F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VCNX Stock Option (Right to Buy) Disposed to Issuer $8,694 -11,291 -100% $0.7700 0 23 Oct 2023 Common Stock 11,291 $1.13 Direct F9
holding VCNX Stock Option (Right to Buy) 426 23 Oct 2023 Common Stock 426 $204.00 Direct F3
holding VCNX Stock Option (Right to Buy) 166 23 Oct 2023 Common Stock 166 $78.90 Direct F3
holding VCNX Stock Option (Right to Buy) 514 23 Oct 2023 Common Stock 514 $116.70 Direct F3, F4
holding VCNX Stock Option (Right to Buy) 159 23 Oct 2023 Common Stock 159 $82.80 Direct F3
holding VCNX Stock Option (Right to Buy) 123 23 Oct 2023 Common Stock 123 $107.55 Direct F3
holding VCNX Stock Option (Right to Buy) 182 23 Oct 2023 Common Stock 182 $72.75 Direct F3
holding VCNX Stock Option (Right to Buy) 222 23 Oct 2023 Common Stock 222 $60.00 Direct F3
holding VCNX Stock Option (Right to Buy) 1,045 23 Oct 2023 Common Stock 1,045 $59.25 Direct F3, F5
holding VCNX Stock Option (Right to Buy) 250 23 Oct 2023 Common Stock 250 $54.15 Direct F3
holding VCNX Stock Option (Right to Buy) 508 23 Oct 2023 Common Stock 508 $26.70 Direct F3
holding VCNX Stock Option (Right to Buy) 436 23 Oct 2023 Common Stock 436 $31.05 Direct F3
holding VCNX Stock Option (Right to Buy) 302 23 Oct 2023 Common Stock 302 $44.70 Direct F3
holding VCNX Stock Option (Right to Buy) 1,905 23 Oct 2023 Common Stock 1,905 $32.25 Direct F3, F6
holding VCNX Stock Option (Right to Buy) 320 23 Oct 2023 Common Stock 320 $42.00 Direct F3
holding VCNX Stock Option (Right to Buy) 415 23 Oct 2023 Common Stock 415 $32.40 Direct F3
holding VCNX Stock Option (Right to Buy) 857 23 Oct 2023 Common Stock 857 $15.60 Direct F3
holding VCNX Stock Option (Right to Buy) 668 23 Oct 2023 Common Stock 668 $19.80 Direct F3
holding VCNX Stock Option (Right to Buy) 3,550 23 Oct 2023 Common Stock 3,550 $16.80 Direct F3, F7
holding VCNX Stock Option (Right to Buy) 804 23 Oct 2023 Common Stock 804 $16.20 Direct F3
holding VCNX Stock Option (Right to Buy) 1,750 23 Oct 2023 Common Stock 1,750 $7.43 Direct F3
holding VCNX Stock Option (Right to Buy) 1,323 23 Oct 2023 Common Stock 1,323 $9.68 Direct F3
holding VCNX Stock Option (Right to Buy) 2,140 23 Oct 2023 Common Stock 2,140 $5.99 Direct F3
holding VCNX Stock Option (Right to Buy) 9,589 23 Oct 2023 Common Stock 9,589 $6.15 Direct F8
holding VCNX Stock Option (Right to Buy) 2,414 23 Oct 2023 Common Stock 2,414 $5.34 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Mr. Frieberg's spouse is the owner of Benbow Estates, Ltd. and Mr. Frieberg is an officer of Benbow Estates, Ltd. Mr. Frieberg disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
F2 Mr. Frieberg is the sole owner and President of Gee Eff Services Limited.
F3 Exercisable in full as of the date of this report.
F4 This option expires on May 14, 2029 or five years following retirement or cessation of services, whichever occurs first.
F5 This option expires on May 12, 2030 or five years following retirement or cessation of services, whichever occurs first.
F6 This option expires on May 9, 2031 or five years following retirement or cessation of services, whichever occurs first.
F7 This option expires on May 9, 2032 or five years following retirement or cessation of services, whichever occurs first.
F8 This option expires on May 8, 2033 or five years following retirement or cessation of services, whichever occurs first.
F9 This option was canceled by mutual agreement of the reporting person and Vaccinex, Inc. The reporting person received $8,750 as consideration for the cancellation, which represents the reporting person's retainer and meeting fees during the third quarter of 2023.

Remarks:

On September 25, 2023, Vaccinex, Inc. effected a 1-for-15 reverse stock split (the "Reverse Stock Split"). The number of stock options and underlying shares of common stock in this Form 4 reflect the Reverse Stock Split.